Development of myasthenia gravis during interferon-alpha treatment for anti-HCV positive chronic hepatitis.
AUTOR(ES)
Mase, G
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1073867Documentos Relacionados
- Myasthenia gravis in a patient with chronic active hepatitis C during interferon-alpha treatment.
- Low dose interferon-alpha is safe in patients with myasthenia gravis.
- Interferon-alpha receptor 1 mRNA expression in peripheral blood mononuclear cells is associated with response to interferon-alpha therapy of patients with chronic hepatitis C
- Alanine aminotransferase assay to detect anti-HCV positive subjects in non-selected populations.
- Thyroid hormonal disturbances related to treatment of hepatitis C with interferon-alpha and ribavirin